Compare Globus Medical Inc. Class A Common Stock (GMED) vs Harley-Davidson Inc (HOG) Price & Performance

Globus Medical (GMED) trades at $76.32, showing minimal daily movement with a 0.1% gain. The stock demonstrates strong fundamental performance with consistent earnings beats in recent quarters and robust profitability metrics including 68.55% gross margins and 17.03% net income margins. Technical indicators suggest neutral positioning near key support at $73 with resistance at $74. Recent developments include new product showcases at industry conferences and upcoming Q3 earnings release.

GMED presents a compelling investment case with strong analyst support (72% buy rating) and 25% upside to consensus target of $95.13. The company maintains solid revenue growth trajectory and debt-free balance sheet, though investors should monitor competitive pressures in medical devices and potential margin compression as revenue scales. Near-term catalysts include Q3 earnings results expected November 5, 2026.

Harley-Davidson (HOG) trades at $26.96, down 1.5% on the day, with a bullish technical signal from moving averages but mixed oscillators. The company reported a Q2 2026 EPS beat ($0.75 actual vs. $0.645 expected) but missed in Q4 2025 and Q1 2026. Revenue has declined from $5.8B in 2022 to $4.5B in 2025, with net income margin falling to 4.78%. Recent news highlights tariff risks and a data breach investigation, while analyst consensus is a $28.50 price target with a Hold-heavy rating.

The outlook is cautious; HOG faces revenue pressure and margin compression, offset by low valuation multiples (P/E 15.26, P/S 0.74) and a dividend. Key risks include competitive threats, tariff exposure, and economic sensitivity. Upside depends on execution of the 'Back to the Bricks' plan stabilizing sales, but investor sentiment remains neutral amid institutional selling and mixed earnings trends.